CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
17.715
0.03%
Market Trading Hours* (UTC) Opens on Tuesday at 07:00

Tue - Fri: 07:00 - 11:00 11:03 - 15:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.055
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.025295 %
Charges from full value of position ($-4.81)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.025295%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.003377 %
Charges from full value of position ($0.64)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003377%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.1
Currency GBP
Margin 5%
Stock exchange United Kingdom of Great Britain and Northern Ireland
Commission on trade 0%

Key Stats
Prev. Close 17.71
Open 17.715
1-Year Change 24.1%
Day's Range 17.715 - 17.9
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
May 24, 2024 17.715 -0.050 -0.28% 17.765 17.905 17.635
May 23, 2024 17.710 -0.230 -1.28% 17.940 18.055 17.705
May 22, 2024 17.850 0.510 2.94% 17.340 17.895 17.340
May 21, 2024 17.425 -0.230 -1.30% 17.655 17.655 17.380
May 20, 2024 17.600 -0.120 -0.68% 17.720 17.760 17.600
May 17, 2024 17.610 -0.050 -0.28% 17.660 17.765 17.610
May 16, 2024 17.765 -0.055 -0.31% 17.820 18.000 17.735
May 15, 2024 17.945 -0.130 -0.72% 18.075 18.175 17.945
May 14, 2024 18.080 0.100 0.56% 17.980 18.105 17.860
May 13, 2024 18.045 0.145 0.81% 17.900 18.070 17.890
May 10, 2024 17.935 0.135 0.76% 17.800 17.970 17.770
May 9, 2024 17.760 0.060 0.34% 17.700 17.840 17.665
May 8, 2024 17.580 0.055 0.31% 17.525 17.735 17.525
May 7, 2024 17.555 0.215 1.24% 17.340 17.650 17.310
May 3, 2024 17.300 0.000 0.00% 17.300 17.370 17.205
May 2, 2024 17.255 0.250 1.47% 17.005 17.270 16.900
May 1, 2024 16.985 0.320 1.92% 16.665 17.155 16.635
Apr 30, 2024 16.715 0.220 1.33% 16.495 16.775 16.495
Apr 29, 2024 16.685 0.280 1.71% 16.405 16.745 16.405
Apr 26, 2024 16.515 0.240 1.47% 16.275 16.525 16.275

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

GSK Company profile

GlaxoSmithKline PLC - GSK CFD

GlaxoSmithKline (GSK) is a global healthcare company focussed in pharmaceuticals, vaccine development and consumer healthcare products. 

The company began as an apothecary shop in London in 1715. Today, GlaxoSmithKline is headquartered in Brentford, England, with regional offices in the US and Singapore. GlaxoSmithKline’s primary listing is on the London Stock Exchange under the ticker symbol ‘GSK’. The GSK stock price in the form of  American depositary shares is listed on the New York Stock Exchange.   

GlaxoSmithKline’s pharmaceutical business covers a broad portfolio of medicines in respiratory, HIV, immuno-inflammation and oncology. The company has a leadership position in respiratory disease medicines. GlaxoSmithKline’s HIV business is managed through its unit ViiV Healthcare, with Pfizer and Shionogi as minority shareholders. 

In addition to respiratory and HIV treatments, the company has a portfolio of pharmaceutical products for the treatment of conditions such as lupus, urology and anti-infectives. 

Its Established Products Portfolio (EPP) includes mature medicines in the areas of anti-infectives, allergy, central nervous system, dermatology, respiratory and urology. These products are an important part of our Emerging Markets business.

GlaxoSmithKline is actively researching the World Health Organisation’s three priority diseases - HIV/AIDS, tuberculosis and malaria.

GlaxoSmithKline is also one of the world’s largest vaccine companies with a portfolio of more than 20 vaccines. The company has 12 vaccine manufacturing sites around the world. One of its four global R&D centres is dedicated to mRNA technology.

GlaxoSmithKline’s consumer healthcare business has portfolio of brands that include Sensodyne, Parodontax, Polident, Advil, Voltaire, Panadol, Striven, Theraflu and Centrum across oral health, pain relief, cold, flu and allergy, digestive health, and vitamins, mineral and supplements segments. GlaxoSmithKline is set to spin-off its consumer healthcare business into an independent company under the name ‘Haleon’.’

The company pays dividends on a quarterly basis, in July, October, January and April.
Follow the GlaxoSmithKline stock price live at Capital.com today.

Industry: Pharmaceuticals (NEC)

980 Great West Road
BRENTFORD
MIDDLESEX TW8 9GS
GB

News

Copper price slumps as traders take profits, where to next?

Copper price drops over 5% on Thursday as traders take profits following the FOMC meeting minutes.

16:17, 24 May 2024

Market analysis: EUR/GBP driven by diverging policy expectations

The EURGBP is driven by the question: which cuts first, the ECB or the BOE? Currently, swaps markets (chart below) imply that it will be the ECB (blue line).

13:46, 24 May 2024

UK CPI Preview: Will inflation return to 2% as the BoE predicts? And how will it affect GBP?

The latest round of inflation data will be released at 22 April at 7 am BST and investors are likely going to be paying close attention.

15:44, 21 May 2024

Reserve Bank of New Zealand Preview: RBNZ could become more dovish as inflation eases and growth softens

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, May 22, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

15:29, 21 May 2024

Nvidia Q1 Earnings Preview: Analysts forecast another blockbuster set of results

Nvidia (NVDA) reports its Q1 results after the closing bell on Wednesday, May 22nd. We preview what to expect from Nvidia’s earnings and analyse its stock's technicals.

14:57, 21 May 2024
CPI, consumer price index symbol.

Disinflation resumes in the US as CPI drops in April

The rate of growth in US consumer prices dropped in April leading markets to price in more chances of rate cuts from the Fed

11:24, 16 May 2024

Stock market crash: how far can the S&P 500 go?

After a remarkably strong first quarter, the US stock market pulled back in April for the first time since October last year.

11:46, 10 May 2024

People also watch

US100

18,805.30 Price
+1.000% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

BTC/USD

69,129.05 Price
+0.390% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.55 Price
+1.490% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Gold

2,334.30 Price
+0.240% 1D Chg, %
Long position overnight fee -0.0199%
Short position overnight fee 0.0117%
Overnight fee time 21:00 (UTC)
Spread 0.80

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading